Literature DB >> 17885208

NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).

Kabsun Kim1, Seoung-Hoon Lee, Jung Ha Kim, Yongwon Choi, Nacksung Kim.   

Abstract

NFATc1 has been characterized as a master regulator of nuclear factor kappaB ligand-induced osteoclast differentiation. Herein, we demonstrate a novel role for NFATc1 as a positive regulator of nuclear factor kappaB ligand-mediated osteoclast fusion as well as other fusion-inducing factors such as TNF-alpha. Exogenous overexpression of a constitutively active form of NFATc1 in bone marrow-derived monocyte/macrophage cells (BMMs) induces formation of multinucleated osteoclasts as well as the expression of fusion-mediating molecules such as the d2 isoform of vacuolar ATPase V(o) domain (Atp6v0d2) and the dendritic cell-specific transmembrane protein (DC-STAMP). Moreover, inactivation of NFATc1 by cyclosporin A treatment attenuates expression of Atp6v0d2 and DC-STAMP and subsequent fusion process of osteoclasts. We show that NFATc1 binds to the promoter regions of Atp6v0d2 and DC-STAMP in osteoclasts and directly induces their expression. Furthermore, overexpression of Atp6v0d2 and DC-STAMP rescues cell-cell fusion of preosteoclasts despite reduced NFATc1 activity. Our data indicate for the first time that the NFATc1/Atp6v0d2 and DC-STAMP signaling axis plays a key role in the osteoclast multinucleation process, which is essential for efficient bone resorption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885208      PMCID: PMC2725751          DOI: 10.1210/me.2007-0237

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  37 in total

Review 1.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

2.  Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.

Authors:  Junwon Lee; Kabsun Kim; Jung Ha Kim; Hye Mi Jin; Han Kyung Choi; Seoung-Hoon Lee; Hyun Kook; Kyung Keun Kim; Yoshifumi Yokota; Soo Young Lee; Yongwon Choi; Nacksung Kim
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

3.  Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity.

Authors:  Fumiyo Ikeda; Riko Nishimura; Takuma Matsubara; Kenji Hata; Sakamuri V Reddy; Toshiyuki Yoneda
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

4.  v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.

Authors:  Seoung-Hoon Lee; Jaerang Rho; Daewon Jeong; Jai-Yoon Sul; Taesoo Kim; Nacksung Kim; Ju-Seob Kang; Takeshi Miyamoto; Toshio Suda; Sun-Kyeong Lee; Robert J Pignolo; Boguslawa Koczon-Jaremko; Joseph Lorenzo; Yongwon Choi
Journal:  Nat Med       Date:  2006-11-26       Impact factor: 53.440

5.  Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

Authors:  Takako Koga; Masanori Inui; Kazuya Inoue; Sunhwa Kim; Ayako Suematsu; Eiji Kobayashi; Toshio Iwata; Hiroshi Ohnishi; Takashi Matozaki; Tatsuhiko Kodama; Tadatsugu Taniguchi; Hiroshi Takayanagi; Toshiyuki Takai
Journal:  Nature       Date:  2004-04-15       Impact factor: 49.962

6.  The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells.

Authors:  Hiroaki Hirotani; Nathaniel A Tuohy; Je-Tae Woo; Paula H Stern; Neil A Clipstone
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

7.  NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

Authors:  Tania N Crotti; Merrilee Flannery; Nicole C Walsh; Joseph D Fleming; Steven R Goldring; Kevin P McHugh
Journal:  Gene       Date:  2006-03-02       Impact factor: 3.688

8.  Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR).

Authors:  Satoru Ishikawa; Noriko Arase; Tadashi Suenaga; Yoshitomo Saita; Masaki Noda; Takayuki Kuriyama; Hisashi Arase; Takashi Saito
Journal:  Int Immunol       Date:  2004-06-07       Impact factor: 4.823

9.  RANKL-induced DC-STAMP is essential for osteoclastogenesis.

Authors:  Toshio Kukita; Naohisa Wada; Akiko Kukita; Takashi Kakimoto; Ferry Sandra; Kazuko Toh; Kengo Nagata; Tadahiko Iijima; Madoka Horiuchi; Hiromi Matsusaki; Kunio Hieshima; Osamu Yoshie; Hisayuki Nomiyama
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

10.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

Authors:  Yoshito Takeda; Isao Tachibana; Kenji Miyado; Masatoshi Kobayashi; Toru Miyazaki; Toshiki Funakoshi; Hiromi Kimura; Hiroyuki Yamane; Yoshiyuki Saito; Hiroyuki Goto; Tsutomu Yoneda; Mitsuhiro Yoshida; Toru Kumagai; Tadashi Osaki; Seiji Hayashi; Ichiro Kawase; Eisuke Mekada
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

View more
  168 in total

1.  Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.

Authors:  Jeske J Smink; Per-Ulf Tunn; Achim Leutz
Journal:  J Mol Med (Berl)       Date:  2011-11-10       Impact factor: 4.599

2.  The transmembrane adaptor protein, linker for activation of T cells (LAT), regulates RANKL-induced osteoclast differentiation.

Authors:  Kabsun Kim; Jung Ha Kim; Jang Bae Moon; Jongwon Lee; Han Bok Kwak; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

3.  V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.

Authors:  De-Qin Yang; Shengmei Feng; Wei Chen; Haibo Zhao; Christie Paulson; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

4.  Mitf regulates osteoclastogenesis by modulating NFATc1 activity.

Authors:  Ssu-Yi Lu; Mengtao Li; Yi-Ling Lin
Journal:  Exp Cell Res       Date:  2014-08-22       Impact factor: 3.905

5.  The influence of interleukin-32γ on osteoclastogenesis with a focus on fusion-related genes.

Authors:  Yong-Gil Kim; Min Wook So; Bon San Koo; Eun-Ju Chang; Seok Jong Song; Chang-Keun Lee; Bin Yoo
Journal:  J Clin Immunol       Date:  2011-11-09       Impact factor: 8.317

6.  SLAT negatively regulates RANKL-induced osteoclast differentiation.

Authors:  Bang Ung Youn; Kabsun Kim; Jung Ha Kim; Jongwon Lee; Jang Bae Moon; Inyoung Kim; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2013-08-29       Impact factor: 5.034

7.  Conditional Disruption of miR17~92 in Osteoclasts Led to Activation of Osteoclasts and Loss of Trabecular Bone In Part Through Suppression of the miR17-Mediated Downregulation of Protein-Tyrosine Phosphatase-oc in Mice.

Authors:  Kin-Hing William Lau; Virginia M Stiffel; Charles H Rundle; Mehran Amoui; Jordan Tapia; Tyler D White; Matilda H-C Sheng
Journal:  JBMR Plus       Date:  2017-08-01

8.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

Review 9.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

Review 10.  Osteoclast motility: putting the brakes on bone resorption.

Authors:  Deborah V Novack; Roberta Faccio
Journal:  Ageing Res Rev       Date:  2009-09-27       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.